United States Biotechnology & Medical Research

IRulya Therapeutics Inc (IRLA)

Track

Track

IRulya Therapeutics Inc. recorded one notable insider trading event recently, involving a proposed sale of 3,700 shares valued at $133,328.85 by officer Dirk Thye on October 21, 2026. This activity follows a period where the stock price appreciated significantly, occurring ahead of the upcoming November 11, 2026, earnings report.
Ticker: IRLA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for IRulya Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.3
Dirk Thye Officer Officer
Transaction date
Proposed sale
Price
439.21
Quantity 71,285
Value US$2,490,903
3.3
LUCA BENATTI OFFICER Officer
Transaction date
Proposed sale
Price
112.30
Quantity 55,504
Value US$4,372,320
3.3
Benatti Luca Non-Executive Director
Transaction date
Sale
Price
90.13
Quantity 68,542 -38.6%
Value US$3,914,905
3.3
Thye Dirk CEO AND CHIEF MEDICAL OFFICER Executive Director
Transaction date
Purchase
Price
0.70
Quantity 77,000 +10.0%
Value US$53,900
3.3
Thye Dirk CEO AND CHIEF MEDICAL OFFICER Executive Director
Transaction date
Purchase
Price
0.69
Quantity 77,500 +11.2%
Value US$53,475
3.2
Hannah Brendan CHIEF BUSINESS OFFICER AND COO Officer
Transaction date
Purchase
Price
0.63
Quantity 23,565 +8.6%
Value US$14,846
3.2
Hannah Brendan CHIEF BUSINESS OFFICER AND COO Officer
Transaction date
Purchase
Price
0.62
Quantity 5,000 +1.9%
Value US$3,100
3.2
Hannah Brendan CHIEF BUSINESS OFFICER AND COO Officer
Transaction date
Purchase
Price
0.61
Quantity 2,280 +0.9%
Value US$1,391
3.3
Ryan Charles S. PRESIDENT Officer
Transaction date
Purchase
Price
0.65
Quantity 48,387 +65.3%
Value US$31,452
3.2
Hannah Brendan CHIEF BUSINESS OFFICER AND COO Officer
Transaction date
Purchase
Price
0.60
Quantity 3,424 +1.3%
Value US$2,054
3.2
Hannah Brendan CHIEF BUSINESS OFFICER AND COO Officer
Transaction date
Purchase
Price
0.61
Quantity 2,500 +1.0%
Value US$1,525
3.2
Hannah Brendan CHIEF BUSINESS OFFICER AND COO Officer
Transaction date
Purchase
Price
0.58
Quantity 2,155 +0.8%
Value US$1,250
3.7
Lamond David Non-Executive Director
Transaction date
Purchase
Price
1.04
Quantity 22,627 +1.0%
Value US$23,532
3.7
Lamond David Non-Executive Director
Transaction date
Purchase
Price
1.00
Quantity 22,627 +1.0%
Value US$22,627
3.7
Lamond David Non-Executive Director
Transaction date
Purchase
Price
1.02
Quantity 22,327 +1.0%
Value US$22,774
3.7
Lamond David Non-Executive Director
Transaction date
Purchase
Price
1.00
Quantity 300 +0.0%
Value US$300
3.7
Lamond David Non-Executive Director
Transaction date
Purchase
Price
1.01
Quantity 19,123 +0.8%
Value US$19,314
3.7
Lamond David Non-Executive Director
Transaction date
Purchase
Price
1.02
Quantity 19,123 +0.9%
Value US$19,505
3.7
Lamond David Non-Executive Director
Transaction date
Purchase
Price
1.01
Quantity 19,123 +0.9%
Value US$19,314
3.7
Lamond David Non-Executive Director
Transaction date
Purchase
Price
0.94
Quantity 14,378 +0.7%
Value US$13,515
3.7
Lamond David Non-Executive Director
Transaction date
Purchase
Price
0.90
Quantity 14,378 +0.7%
Value US$12,940
3.7
Lamond David Non-Executive Director
Transaction date
Purchase
Price
0.98
Quantity 14,378 +0.7%
Value US$14,090
3.7
Lamond David Non-Executive Director
Transaction date
Purchase
Price
1.32
Quantity 41,026 +1.9%
Value US$54,154
3.7
Lamond David Non-Executive Director
Transaction date
Purchase
Price
1.31
Quantity 41,026 +2.0%
Value US$53,744
3.7
Lamond David Non-Executive Director
Transaction date
Purchase
Price
1.29
Quantity 24,766 +1.2%
Value US$31,948
3.7
Lamond David Non-Executive Director
Transaction date
Purchase
Price
1.29
Quantity 117,348 +6.0%
Value US$151,379
3.7
Lamond David Non-Executive Director
Transaction date
Purchase
Price
1.32
Quantity 107,886 +5.8%
Value US$142,410
3.3
Thye Dirk Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.26
Quantity 88,000 +24.4%
Value US$110,880
3.3
Thye Dirk Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.24
Quantity 80,000 +28.5%
Value US$99,200
3.2
Hannah Brendan Chief Business Officer Officer
Transaction date
Purchase
Price
1.22
Quantity 71,762 +55.3%
Value US$87,550
1.3
McLoughlin Margaret Non-Executive Director
Transaction date
Purchase
Price
1.23
Quantity 8,000 +inf%
Value US$9,840
Monohon Ted Chief Accounting Officer & VP Officer
Transaction date
Planned sale
Price
0.98
Quantity 1,871 -6.4%
Value US$1,834
3.3
McDowell Caryn Gordon Chief Legal & Adm. Officer Officer
Transaction date
Sale
Price
2.86
Quantity 10,800 -8.1%
Value US$30,923
0.5
Dominy Stephen S. Chief Scientific Officer Executive Director
Transaction date
Purchase
Price
14.40
Quantity 763 +0.1%
Value US$10,987
1.3
McLoughlin Margaret Non-Executive Director
Transaction date
Planned sale
Price
88.93
Quantity 1,000 -100.0%
Value US$88,930
0.8
LOWE CHRISTOPHER P. COO & Chief Financial Officer Officer
Transaction date
Planned sale
Price
98.50
Quantity 4,963 -7.6%
Value US$488,856
Detke Michael J. Chief Medical Officer Officer
Transaction date
Planned sale
Price
56.99
Quantity 523 -100.0%
Value US$29,806
Detke Michael J. Chief Medical Officer Officer
Transaction date
Planned sale
Price
56.27
Quantity 6,942 -93.0%
Value US$390,626
Detke Michael J. Chief Medical Officer Officer
Transaction date
Planned sale
Price
55.38
Quantity 4,353 -36.8%
Value US$241,069
Detke Michael J. Chief Medical Officer Officer
Transaction date
Planned sale
Price
54.37
Quantity 1,648 -12.2%
Value US$89,602
Detke Michael J. Chief Medical Officer Officer
Transaction date
Planned sale
Price
53.24
Quantity 3,934 -22.6%
Value US$209,446
Detke Michael J. Chief Medical Officer Officer
Transaction date
Planned sale
Price
55.01
Quantity 288 -100.0%
Value US$15,843
Detke Michael J. Chief Medical Officer Officer
Transaction date
Planned sale
Price
53.91
Quantity 8,260 -96.6%
Value US$445,297
Detke Michael J. Chief Medical Officer Officer
Transaction date
Planned sale
Price
53.43
Quantity 32,313 -79.1%
Value US$1,726,484
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
36.73
Quantity 183 -0.0%
Value US$6,722
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
35.81
Quantity 6,315 -0.6%
Value US$226,140
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
34.89
Quantity 9,918 -1.0%
Value US$346,039
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
33.75
Quantity 13,584 -1.3%
Value US$458,460
3.7
Lamond David Non-Executive Director
Transaction date
Purchase
Price
33.77
Quantity 50,000 +2.8%
Value US$1,688,500
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
36.60
Quantity 400 -0.0%
Value US$14,640
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
36.58
Quantity 300 -0.0%
Value US$10,974
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
35.85
Quantity 18,089 -1.8%
Value US$648,491
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
35.10
Quantity 11,211 -1.1%
Value US$393,506
3.7
Lamond David Non-Executive Director
Transaction date
Purchase
Price
36.86
Quantity 4,100 +0.2%
Value US$151,126
3.7
Lamond David Non-Executive Director
Transaction date
Purchase
Price
36.34
Quantity 15,969 +0.9%
Value US$580,313
3.7
Lamond David Non-Executive Director
Transaction date
Purchase
Price
35.00
Quantity 13,310 +0.8%
Value US$465,850
3.7
Lamond David Non-Executive Director
Transaction date
Purchase
Price
34.28
Quantity 16,621 +1.0%
Value US$569,768
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
45.73
Quantity 600 -0.1%
Value US$27,438
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
45.00
Quantity 8,032 -0.8%
Value US$361,440
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
44.22
Quantity 1,900 -0.2%
Value US$84,018
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
43.10
Quantity 1,512 -0.1%
Value US$65,167
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
41.91
Quantity 3,100 -0.3%
Value US$129,921
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
40.84
Quantity 2,000 -0.2%
Value US$81,680
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
39.82
Quantity 856 -0.1%
Value US$34,086
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
38.64
Quantity 1,600 -0.2%
Value US$61,824
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
37.39
Quantity 400 -0.0%
Value US$14,956
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
36.75
Quantity 5,071 -0.5%
Value US$186,359
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
36.02
Quantity 14,929 -1.4%
Value US$537,743
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
39.23
Quantity 371 -0.0%
Value US$14,554
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
38.28
Quantity 100 -0.0%
Value US$3,828
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
37.68
Quantity 4,283 -0.4%
Value US$161,383
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
36.56
Quantity 7,460 -0.7%
Value US$272,738
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
35.59
Quantity 3,100 -0.3%
Value US$110,329
Lynch Casey Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
34.60
Quantity 4,686 -0.4%
Value US$162,136
Holsinger Leslie Executive Vice President Officer
Transaction date
Planned sale
Price
32.59
Quantity 900 -20.5%
Value US$29,331
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-21 2026-10-21 PrS Proposed sale
3.3
Dirk Thye

Officer

Officer
71,285
439.21
US$2,490,903 		71,285 439.21 US$2,490,903
2025-12-29 2025-12-26 PrS Proposed sale
3.3
LUCA BENATTI

OFFICER

Officer
55,504
112.30
US$4,372,320 		55,504 112.30 US$4,372,320
2025-12-29 2025-12-26 S Sale
3.3
Benatti Luca
Non-Executive Director
68,542 -38.6%
90.13
US$3,914,905 		68,542 -38.6% 90.13 US$3,914,905
2024-09-03 2024-08-30 B Purchase
3.3
Thye Dirk

CEO AND CHIEF MEDICAL OFFICER

Executive Director
77,000 +10.0%
0.70
US$53,900 		77,000 +10.0% 0.70 US$53,900
2024-09-03 2024-08-29 B Purchase
3.3
Thye Dirk

CEO AND CHIEF MEDICAL OFFICER

Executive Director
77,500 +11.2%
0.69
US$53,475 		77,500 +11.2% 0.69 US$53,475
2024-08-21 2024-08-21 B Purchase
3.2
Hannah Brendan

CHIEF BUSINESS OFFICER AND COO

Officer
23,565 +8.6%
0.63
US$14,846 		23,565 +8.6% 0.63 US$14,846
2024-08-21 2024-08-21 B Purchase
3.2
Hannah Brendan

CHIEF BUSINESS OFFICER AND COO

Officer
5,000 +1.9%
0.62
US$3,100 		5,000 +1.9% 0.62 US$3,100
2024-08-21 2024-08-21 B Purchase
3.2
Hannah Brendan

CHIEF BUSINESS OFFICER AND COO

Officer
2,280 +0.9%
0.61
US$1,391 		2,280 +0.9% 0.61 US$1,391
2024-08-22 2024-08-20 B Purchase
3.3
Ryan Charles S.

PRESIDENT

Officer
48,387 +65.3%
0.65
US$31,452 		48,387 +65.3% 0.65 US$31,452
2024-08-21 2024-08-20 B Purchase
3.2
Hannah Brendan

CHIEF BUSINESS OFFICER AND COO

Officer
3,424 +1.3%
0.60
US$2,054 		3,424 +1.3% 0.60 US$2,054
2024-08-21 2024-08-20 B Purchase
3.2
Hannah Brendan

CHIEF BUSINESS OFFICER AND COO

Officer
2,500 +1.0%
0.61
US$1,525 		2,500 +1.0% 0.61 US$1,525
2024-08-21 2024-08-19 B Purchase
3.2
Hannah Brendan

CHIEF BUSINESS OFFICER AND COO

Officer
2,155 +0.8%
0.58
US$1,250 		2,155 +0.8% 0.58 US$1,250
2023-12-14 2023-12-14 B Purchase
3.7
Lamond David
Non-Executive Director
22,627 +1.0%
1.04
US$23,532 		22,627 +1.0% 1.04 US$23,532
2023-12-14 2023-12-13 B Purchase
3.7
Lamond David
Non-Executive Director
22,627 +1.0%
1.00
US$22,627 		22,627 +1.0% 1.00 US$22,627
2023-12-14 2023-12-12 B Purchase
3.7
Lamond David
Non-Executive Director
22,327 +1.0%
1.02
US$22,774 		22,327 +1.0% 1.02 US$22,774
2023-12-14 2023-12-12 B Purchase
3.7
Lamond David
Non-Executive Director
300 +0.0%
1.00
US$300 		300 +0.0% 1.00 US$300
2023-12-07 2023-12-07 B Purchase
3.7
Lamond David
Non-Executive Director
19,123 +0.8%
1.01
US$19,314 		19,123 +0.8% 1.01 US$19,314
2023-12-07 2023-12-06 B Purchase
3.7
Lamond David
Non-Executive Director
19,123 +0.9%
1.02
US$19,505 		19,123 +0.9% 1.02 US$19,505
2023-12-07 2023-12-05 B Purchase
3.7
Lamond David
Non-Executive Director
19,123 +0.9%
1.01
US$19,314 		19,123 +0.9% 1.01 US$19,314
2023-12-01 2023-12-01 B Purchase
3.7
Lamond David
Non-Executive Director
14,378 +0.7%
0.94
US$13,515 		14,378 +0.7% 0.94 US$13,515
2023-12-01 2023-11-30 B Purchase
3.7
Lamond David
Non-Executive Director
14,378 +0.7%
0.90
US$12,940 		14,378 +0.7% 0.90 US$12,940
2023-12-01 2023-11-29 B Purchase
3.7
Lamond David
Non-Executive Director
14,378 +0.7%
0.98
US$14,090 		14,378 +0.7% 0.98 US$14,090
2023-08-31 2023-08-31 B Purchase
3.7
Lamond David
Non-Executive Director
41,026 +1.9%
1.32
US$54,154 		41,026 +1.9% 1.32 US$54,154
2023-08-31 2023-08-30 B Purchase
3.7
Lamond David
Non-Executive Director
41,026 +2.0%
1.31
US$53,744 		41,026 +2.0% 1.31 US$53,744
2023-08-17 2023-08-17 B Purchase
3.7
Lamond David
Non-Executive Director
24,766 +1.2%
1.29
US$31,948 		24,766 +1.2% 1.29 US$31,948
2023-08-17 2023-08-16 B Purchase
3.7
Lamond David
Non-Executive Director
117,348 +6.0%
1.29
US$151,379 		117,348 +6.0% 1.29 US$151,379
2023-08-17 2023-08-15 B Purchase
3.7
Lamond David
Non-Executive Director
107,886 +5.8%
1.32
US$142,410 		107,886 +5.8% 1.32 US$142,410
2023-08-11 2023-08-10 B Purchase
3.3
Thye Dirk

Chief Executive Officer

Executive Director
88,000 +24.4%
1.26
US$110,880 		88,000 +24.4% 1.26 US$110,880
2023-08-09 2023-08-08 B Purchase
3.3
Thye Dirk

Chief Executive Officer

Executive Director
80,000 +28.5%
1.24
US$99,200 		80,000 +28.5% 1.24 US$99,200
2023-08-09 2023-08-08 B Purchase
3.2
Hannah Brendan

Chief Business Officer

Officer
71,762 +55.3%
1.22
US$87,550 		71,762 +55.3% 1.22 US$87,550
2023-08-09 2023-08-08 B Purchase
1.3
McLoughlin Margaret
Non-Executive Director
8,000 +inf%
1.23
US$9,840 		8,000 +inf% 1.23 US$9,840
2023-03-06 2023-03-06 PlS Planned sale
Monohon Ted

Chief Accounting Officer & VP

Officer
1,871 -6.4%
0.98
US$1,834 		1,871 -6.4% 0.98 US$1,834
2022-06-08 2022-06-06 S Sale
3.3
McDowell Caryn Gordon

Chief Legal & Adm. Officer

Officer
10,800 -8.1%
2.86
US$30,923 		10,800 -8.1% 2.86 US$30,923
2021-11-12 2021-11-12 B Purchase
0.5
Dominy Stephen S.

Chief Scientific Officer

Executive Director
763 +0.1%
14.40
US$10,987 		763 +0.1% 14.40 US$10,987
2021-10-12 2021-10-08 PlS Planned sale
1.3
McLoughlin Margaret
Non-Executive Director
1,000 -100.0%
88.93
US$88,930 		1,000 -100.0% 88.93 US$88,930
2021-10-07 2021-10-05 PlS Planned sale
0.8
LOWE CHRISTOPHER P.

COO & Chief Financial Officer

Officer
4,963 -7.6%
98.50
US$488,856 		4,963 -7.6% 98.50 US$488,856
2021-07-07 2021-07-07 PlS Planned sale
Detke Michael J.

Chief Medical Officer

Officer
523 -100.0%
56.99
US$29,806 		523 -100.0% 56.99 US$29,806
2021-07-07 2021-07-07 PlS Planned sale
Detke Michael J.

Chief Medical Officer

Officer
6,942 -93.0%
56.27
US$390,626 		6,942 -93.0% 56.27 US$390,626
2021-07-07 2021-07-07 PlS Planned sale
Detke Michael J.

Chief Medical Officer

Officer
4,353 -36.8%
55.38
US$241,069 		4,353 -36.8% 55.38 US$241,069
2021-07-07 2021-07-07 PlS Planned sale
Detke Michael J.

Chief Medical Officer

Officer
1,648 -12.2%
54.37
US$89,602 		1,648 -12.2% 54.37 US$89,602
2021-07-07 2021-07-07 PlS Planned sale
Detke Michael J.

Chief Medical Officer

Officer
3,934 -22.6%
53.24
US$209,446 		3,934 -22.6% 53.24 US$209,446
2021-07-07 2021-07-06 PlS Planned sale
Detke Michael J.

Chief Medical Officer

Officer
288 -100.0%
55.01
US$15,843 		288 -100.0% 55.01 US$15,843
2021-07-07 2021-07-06 PlS Planned sale
Detke Michael J.

Chief Medical Officer

Officer
8,260 -96.6%
53.91
US$445,297 		8,260 -96.6% 53.91 US$445,297
2021-07-07 2021-07-06 PlS Planned sale
Detke Michael J.

Chief Medical Officer

Officer
32,313 -79.1%
53.43
US$1,726,484 		32,313 -79.1% 53.43 US$1,726,484
2021-05-12 2021-05-10 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
183 -0.0%
36.73
US$6,722 		183 -0.0% 36.73 US$6,722
2021-05-12 2021-05-10 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
6,315 -0.6%
35.81
US$226,140 		6,315 -0.6% 35.81 US$226,140
2021-05-12 2021-05-10 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
9,918 -1.0%
34.89
US$346,039 		9,918 -1.0% 34.89 US$346,039
2021-05-12 2021-05-10 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
13,584 -1.3%
33.75
US$458,460 		13,584 -1.3% 33.75 US$458,460
2021-03-24 2021-03-24 B Purchase
3.7
Lamond David
Non-Executive Director
50,000 +2.8%
33.77
US$1,688,500 		50,000 +2.8% 33.77 US$1,688,500
2021-03-23 2021-03-22 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
400 -0.0%
36.60
US$14,640 		400 -0.0% 36.60 US$14,640
2021-03-23 2021-03-22 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
300 -0.0%
36.58
US$10,974 		300 -0.0% 36.58 US$10,974
2021-03-23 2021-03-22 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
18,089 -1.8%
35.85
US$648,491 		18,089 -1.8% 35.85 US$648,491
2021-03-23 2021-03-22 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
11,211 -1.1%
35.10
US$393,506 		11,211 -1.1% 35.10 US$393,506
2021-03-05 2021-03-04 B Purchase
3.7
Lamond David
Non-Executive Director
4,100 +0.2%
36.86
US$151,126 		4,100 +0.2% 36.86 US$151,126
2021-03-05 2021-03-04 B Purchase
3.7
Lamond David
Non-Executive Director
15,969 +0.9%
36.34
US$580,313 		15,969 +0.9% 36.34 US$580,313
2021-03-05 2021-03-04 B Purchase
3.7
Lamond David
Non-Executive Director
13,310 +0.8%
35.00
US$465,850 		13,310 +0.8% 35.00 US$465,850
2021-03-05 2021-03-04 B Purchase
3.7
Lamond David
Non-Executive Director
16,621 +1.0%
34.28
US$569,768 		16,621 +1.0% 34.28 US$569,768
2021-02-03 2021-02-03 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
600 -0.1%
45.73
US$27,438 		600 -0.1% 45.73 US$27,438
2021-02-03 2021-02-03 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
8,032 -0.8%
45.00
US$361,440 		8,032 -0.8% 45.00 US$361,440
2021-02-03 2021-02-03 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
1,900 -0.2%
44.22
US$84,018 		1,900 -0.2% 44.22 US$84,018
2021-02-03 2021-02-03 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
1,512 -0.1%
43.10
US$65,167 		1,512 -0.1% 43.10 US$65,167
2021-02-03 2021-02-03 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
3,100 -0.3%
41.91
US$129,921 		3,100 -0.3% 41.91 US$129,921
2021-02-03 2021-02-03 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
2,000 -0.2%
40.84
US$81,680 		2,000 -0.2% 40.84 US$81,680
2021-02-03 2021-02-03 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
856 -0.1%
39.82
US$34,086 		856 -0.1% 39.82 US$34,086
2021-02-03 2021-02-03 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
1,600 -0.2%
38.64
US$61,824 		1,600 -0.2% 38.64 US$61,824
2021-02-03 2021-02-03 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
400 -0.0%
37.39
US$14,956 		400 -0.0% 37.39 US$14,956
2021-02-03 2021-02-02 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
5,071 -0.5%
36.75
US$186,359 		5,071 -0.5% 36.75 US$186,359
2021-02-03 2021-02-02 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
14,929 -1.4%
36.02
US$537,743 		14,929 -1.4% 36.02 US$537,743
2021-02-03 2021-02-01 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
371 -0.0%
39.23
US$14,554 		371 -0.0% 39.23 US$14,554
2021-02-03 2021-02-01 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
100 -0.0%
38.28
US$3,828 		100 -0.0% 38.28 US$3,828
2021-02-03 2021-02-01 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
4,283 -0.4%
37.68
US$161,383 		4,283 -0.4% 37.68 US$161,383
2021-02-03 2021-02-01 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
7,460 -0.7%
36.56
US$272,738 		7,460 -0.7% 36.56 US$272,738
2021-02-03 2021-02-01 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
3,100 -0.3%
35.59
US$110,329 		3,100 -0.3% 35.59 US$110,329
2021-02-03 2021-02-01 PlS Planned sale
Lynch Casey

Chief Executive Officer

Executive Director
4,686 -0.4%
34.60
US$162,136 		4,686 -0.4% 34.60 US$162,136
2020-12-15 2020-12-14 PlS Planned sale
Holsinger Leslie

Executive Vice President

Officer
900 -20.5%
32.59
US$29,331 		900 -20.5% 32.59 US$29,331
Explore more

More insider trading research around IRulya Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America